Today’s episode features Amy Emerson, the CEO of MAPS Public Benefit Corporation (PBC), which is a fully owned subsidiary of MAPS, and its purpose is to commercialize MDMA-assisted therapy. We discuss the MAPS PBC and it’s business model for MDMA-assisted therapy.

In this episode, we discuss:

• MAPS’ protocol and strategy behind FDA clinical trial for PTSD
• Amy’s views on the state of the industry, patents, and how to prioritize accessibility
• The unique business model between MAPS and MAPS PBC
• Psychedelics for kids

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin and Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music: Focus Does the Girl by Muted Circus